tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFs
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

IFRX Stock Latest News

InflaRx’s Strategic Shift to INF904: A Prudent Move with Promising Prospects
RatingsInflaRx’s Strategic Shift to INF904: A Prudent Move with Promising Prospects
24d ago
IFRX
InflaRx’s Strategic Shift to INF904: A Promising Focus Amidst Early-Stage Uncertainty
PremiumRatings
InflaRx’s Strategic Shift to INF904: A Promising Focus Amidst Early-Stage Uncertainty
25d ago
IFRX
InflaRx price target lowered to $3 from $6 at Oppenheimer
PremiumThe Fly
InflaRx price target lowered to $3 from $6 at Oppenheimer
25d ago
IFRX
InflaRx downgraded to Outperform from Strong Buy at Raymond James
PremiumThe Fly
InflaRx downgraded to Outperform from Strong Buy at Raymond James
25d ago
IFRX
InflaRx Stock (IFRX) Plummets 55% on Clinical Failure
PremiumMarket News
InflaRx Stock (IFRX) Plummets 55% on Clinical Failure
26d ago
IFRX
Morning News Wrap-Up: Wednesday’s Biggest Stock Market Stories
PremiumMarket NewsMorning News Wrap-Up: Wednesday’s Biggest Stock Market Stories
26d ago
M
KO
InflaRx Halts Vilobelimab Phase 3 Trial for Pyoderma Gangrenosum
Premium
Company Announcements
InflaRx Halts Vilobelimab Phase 3 Trial for Pyoderma Gangrenosum
26d ago
6K
IFRX
InflaRx to discontinue vilobelimab indication following IDMC recommendation
Premium
The Fly
InflaRx to discontinue vilobelimab indication following IDMC recommendation
26d ago
IFRX
InflaRx N.V. Reports Q1 2025 Financial Results
PremiumCompany Announcements
InflaRx N.V. Reports Q1 2025 Financial Results
2M ago
IFRX
InflaRx Reports Q1 2025 Financial Results with Reduced Losses
PremiumCompany Announcements
InflaRx Reports Q1 2025 Financial Results with Reduced Losses
2M ago
6K
IFRX
InflaRx reports Q1 EPS (EUR 0.13) vs (EUR 0.17) last year
PremiumThe Fly
InflaRx reports Q1 EPS (EUR 0.13) vs (EUR 0.17) last year
2M ago
IFRX
Cantor starts InflaRx at Overweight ahead of upcoming Phase 3 data
PremiumThe Fly
Cantor starts InflaRx at Overweight ahead of upcoming Phase 3 data
2M ago
IFRX
InflaRx initiated with an Overweight at Cantor Fitzgerald
PremiumThe FlyInflaRx initiated with an Overweight at Cantor Fitzgerald
2M ago
IFRX
InflaRx Approves Key Resolutions at Annual Shareholder Meeting
Premium
Company Announcements
InflaRx Approves Key Resolutions at Annual Shareholder Meeting
2M ago
6K
IFRX
InflaRx N.V. Announces 2025 Annual General Meeting Agenda
Premium
Company Announcements
InflaRx N.V. Announces 2025 Annual General Meeting Agenda
3M ago
6K
IFRX
InflaRx’s Promising Drug Pipeline and Market Potential Drive Buy Rating
PremiumRatings
InflaRx’s Promising Drug Pipeline and Market Potential Drive Buy Rating
3M ago
IFRX
InflaRx price target raised to $10 from $7 at Guggenheim
PremiumThe Fly
InflaRx price target raised to $10 from $7 at Guggenheim
3M ago
IFRX
Promising Prospects for InflaRx’s Gohibic: Buy Rating Supported by Positive Phase 3 Developments and Market Potential
PremiumRatings
Promising Prospects for InflaRx’s Gohibic: Buy Rating Supported by Positive Phase 3 Developments and Market Potential
3M ago
IFRX
InflaRx N.V. Reports 2024 Results and Key Achievements
PremiumCompany Announcements
InflaRx N.V. Reports 2024 Results and Key Achievements
3M ago
IFRX
InflaRx Reports 2024 Results and Outlines 2025 Milestones
PremiumCompany AnnouncementsInflaRx Reports 2024 Results and Outlines 2025 Milestones
3M ago
6K
IFRX
InflaRx reports Q EPS (EUR 0.78) vs (EUR 0.78) last year
Premium
The Fly
InflaRx reports Q EPS (EUR 0.78) vs (EUR 0.78) last year
3M ago
IFRX
InflaRx reports Q EPS (EUR 0.78) vs (EUR 0.78) last year
Premium
The Fly
InflaRx reports Q EPS (EUR 0.78) vs (EUR 0.78) last year
3M ago
IFRX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >